ASMI welcomes Dr Lance Emerson to the PSA

08 May 2014

Return to Media Release Index

8 May 2014 - The Australian Self Medication Industry (ASMI) today congratulated Dr Lance Emerson on his appointment as Chief Executive Officer of the Pharmaceutical Society of Australia (PSA).

In welcoming Dr Emerson to his new role ASMI Executive Director Deon Schoombie said Dr Emerson brings a wealth of experience to the pharmaceutical sector.

Dr Schoombie said that ASMI has a long history of working closely with the PSA on a range of sectoral issues and he looks forward to continuing this relationship in the future.

About ASMI: The Australian Self-Medication Industry (ASMI) is the peak body representing sponsors of non-prescription medicines - over-the-counter (OTC) and complementary medicines. Its members make up 85 per cent of the $4bn self care market. Membership totals 60 companies and ASMI members employ approximately 17,000 people with exports estimated at $600 million annually. ASMI's mission is to promote better health through responsible self care. This means ensuring that safe and effective self care products are readily available to all Australians at a reasonable cost. ASMI works to encourage responsible use by consumers and an increasing role for cost-effective self-medication products as part of the broad national health strategy.

For more information or to arrange a media interview, please contact:
Marie Kelly-Davies
PR Manager, Australian Self Medication Industry (ASMI)
M:0408 256 381 E: